U.S. market Closed. Opens in 11 hours 31 minutes

AHCO | AdaptHealth Corp. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for AHCO we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is frighteningly weak.

Valuation (48%)

Company Industry
P/E Ratio (TTM) -2.18 40.66
PEG Ratio (TTM) -0.15 5.42
P/S Ratio (TTM) 0.47 6.33
P/B Ratio (TTM) 1.02 5.87
P/FCF Ratio (TTM) 9.17 37.81
Price to 5YR AVG Earnings Ratio -14.36 59.41
Price to 5YR AVG FCF Ratio 19.38 36.98

Profitability (5%)

Company Industry
ROA (TTM) -15.33% 4.66%
ROE (TTM) -44.99% 25.49%
Net Profit Margin (TTM) -21.20% 7.22%
ROIC 5YR AVG 5.60% 6.54%

Growth (60%)

4QTR AVG 3YR AVG 5YR AVG
EPS -605.02% 200.33% -105.14%
Revenue 0.53% 95.07% 62.79%
Net Income -548.72% 90.91% -172.46%
Cash Flow 76.74% 84.34% 63.44%

Health (23%)

Company Industry
Current Ratio (TTM) 1.15 2.64
Quick Ratio (TTM) 0.94 1.97
D/E Ratio (TTM) 1.43 0.55
Interest Coverage (TTM) -1.85 2.38
Piotroski F-Score 5 6
Altman Z-Score 0.41 7.18
LTL to 5YR AVG FCF 26.65 3.69
Shares Outstanding Growth 5YR AVG 51.97% 1.65%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙